Alnylam Pharmaceuticals
ALNY
#438
Rank
โ‚ฌ45.69 B
Marketcap
345,91ย โ‚ฌ
Share price
1.68%
Change (1 day)
48.97%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company